1. Introduction {#sec1}
===============

Infectious laryngotracheitis (ILT) is classified as a*gallid herpesvirus 1* which belongs to the fay Herpesviridae, genus Iltovirus \[[@B1]--[@B3]\]. The virus is included within List E of the Office International des Epizooties (OIE). It causes a major viral respiratory disease of chicken \[[@B2]\]. The disease causes marked economic losses of poultry industry with mortality reaching 70%, especially in high- density poultry-producing regions \[[@B3]\]. High mortality, demonstrated by the severe form of the disease, is a result of severe tracheal lesions in the respiratory tract, significant respiratory distress, expectoration of bloody sputum, sneezing and persistent nasal discharge decreased egg production, weight loss, and susceptibility to infections with other pathogens \[[@B4]\]. The mild form exhibited low mortality, mucoid tracheitis, and sinusitis \[[@B5], [@B6]\].

Vaccination against the viral diseases is very important for protection, due to the lack of appropriate antiviral drugs, high cost, and time consuming of development of new antiviral drugs. Different types of vaccines are available for ILTV such as vaccines produced in chicken-embryo-origin (CEO), tissue-culture-origin (TCO), and recombinant vaccines \[[@B5]\]. However, vaccination against ILTV is recommended only in endemic areas to prevent transmission of the virus by latent infected carriers\' birds to nonvaccinated healthy flocks \[[@B1], [@B7], [@B8]\]. Moreover current vaccines are themselves mildly pathogenic and modified live ILT vaccines increase the virulence of the disease by mutation during bird-to-bird passage in the field \[[@B2], [@B9], [@B10]\]. DNA encoding glycoprotein B vaccine was found to give levels of protection when given intramuscularly comparable to traditional live-attenuated ILTV vaccines. Glycoprotein B and D genes of ILTV have been used to produce immunogenic proteins to elicit protective immune response. These glycoproteins which are located on the viral envelope and the surface of infected cells are required for viral attachment \[[@B1]\]. Developing of new drugs to treat viral diseases is very expensive and time consuming. Therefore, vaccines remain the best choice to protect animals and humans from viruses and other pathogens. In addition traditional techniques of live-attenuated or inactivated vaccines have the risk of allergic reactions. Peptide vaccines are economically reasonable, require less time for development, and hold the promise of multivalent dosages \[[@B11]--[@B13]\]. Recently, bioinformatics software has been used largely to design synthetic peptide vaccines, based on B and T cell responses \[[@B14]\]. The design of multipeptide vaccines using computational model that links various immunoinformatic prediction tools is known to produce satisfactory results \[[@B15], [@B16]\]. The safety, accuracy, feasibility, and speed of these vaccines were well discussed through various computational studies \[[@B17], [@B18]\]. Thus, it is essential to design safe effective vaccine against ILTV that prevents birds from being carriers of the disease using bioinformatics tools. The aim of the present study was to design a vaccine for ILT virus using peptides predicted from glycoproteins especially type B as an immunogen to stimulate protective immune response. The reason of selecting glycoprotein B as a target is due to its function in host attachment and in stimulating immune response in the host.

2. Materials and Methods {#sec2}
========================

2.1. Protein Sequence Retrieval and Phylogeny {#sec2.1}
---------------------------------------------

Forty-four envelope glycoprotein B (GB) sequences of virulent isolates of ILTV were retrieved from GenBank of National Center for Biotechnology Information (NCBI) (<http://www.ncbi.nlm.nih.gov/protein>) in August 2017. The strains of the virus were isolated from chicken from different geographic regions. Complete sequences of all gene subtypes were selected for various immune-bioinformatics analysis. Retrieved strains and their accession numbers and geographical regions are listed in [Table 1](#tab1){ref-type="table"}.

2.2. Phylogenetic Evolution {#sec2.2}
---------------------------

Phylogenetic tree of the retrieved sequences of glycoprotein B of ILTV was created using phylogeny.fr online software (<http://phylogeny.lirmm.fr/phylo_cgi/index.cgi>) \[[@B19]\].

2.3. Multiple Sequence Alignment {#sec2.3}
--------------------------------

The retrieved sequences of ILTV glycoprotein B (GB) were subjected to multiple sequence alignments (MSA) to obtain the conserve regions. This was performed using BioEdit software version 7.2.5 with the aid of ClustalW as applied in the BioEdit program to construct the alignment \[[@B20]\].

2.4. Sequence-Based Method {#sec2.4}
--------------------------

The reference sequence (YP_182356.1) of ILT virus glycoprotein B (GB) was submitted to different prediction tools at the Immune Epitope Database analysis resource (<http://www.iedb.org/>). Epitope analysis resources were used to predict B and T cell epitopes \[[@B21]\]. Predicted epitopes were then investigated in aligned retrieved GB sequences after MSA for conservancy. Conserved epitopes would be considered as candidate epitopes for B and T cells.

### 2.4.1. B Cell Epitope Prediction {#sec2.4.1}

Identification of the surface accessibility, hydrophobicity, flexibility, and antigenicity was performed by analyzing candidate epitopes using several B cell prediction methods from Immune Epitope Database (<http://tools.iedb.org/bcell/>). BepiPred linear epitope prediction from Immune Epitope Database (<http://tools.iedb.org/bcell/result/>) was used to predict linear B cell epitopes with default threshold -.012 \[[@B22]\]. Emini surface accessibility prediction tool of IEDB was performed to detect the surface accessible epitopes with default threshold 1.000 \[[@B23]\], while the prediction of epitopes antigenicity sites of candidate epitopes was achieved to identify the antigenic sites using Kolaskar and Tongaonker antigenicity method (<http://tools.immuneepitope.org/bcell/>) with default threshold 1.027 \[[@B24]\]. The thresholds of these methods are demonstrated in [Figure 1](#fig1){ref-type="fig"}.

### 2.4.2. T Cell Epitope Prediction {#sec2.4.2}

*(1) Cytotoxic T-Lymphocyte Epitopes Prediction and Interaction with MHC- I*. The major histocompatibility complex-1 (MHC class I) binding prediction tool (<http://tools.iedb.org/mhci/>) was used to predict Cytotoxic T cell epitopes \[[@B25]\]. Analysis was achieved using human HLA alleles, due to the lack of chicken alleles in IEDB data set. Artificial neural network (ANN) was used to predict the binding affinity \[[@B26], [@B27]\]. Peptide length for all selected epitopes was set to 9 amino acids (mers). The half-maximal inhibitory concentration (IC50) values required for the peptide\'s binding to the specific MHC-I molecules were set less than or equal to 300 nM.

*(2) Prediction of T Cell Epitopes and Interaction with MHC Class II*. The MHC class II binding prediction tool (<http://tools.iedb.org/mhcii/>) was used to predict T cell epitopes. IC50 for strong binding peptides was set less than 1000 to determine the interaction potentials of T cell epitopes and MHC class II allele (HLA DR, DP and DQ). Human MHC class I and II alleles were used in this study due to the difficulty to determine MHC B complex alleles in poultry. NN-align method was also used with IC50 less than or equal to 1000 nM \[[@B28]\]. Peptides with low IC50 value were proposed to be promising MHC-II epitopes.

2.5. Homology Modeling {#sec2.5}
----------------------

### 2.5.1. Structural Prediction of the Reference Sequence of ILTV Glycoprotein B {#sec2.5.1}

Homology modeling was used for constructing the three-dimensional (3D) structure of the reference sequence of ILTV glycoprotein B. Raptor X structure prediction server ([http://raptorx.uchicago.edu/StructurePrediction/](http://raptorx.uchicago.edu/StructurePrediction/predict/)[predict/](http://raptorx.uchicago.edu/StructurePrediction/predict/)) was used for this purpose. The 3D structure was then treated with Chimera software 1.8 to display the position of proposed epitopes \[[@B29]--[@B32]\].

### 2.5.2. Structure of BF Chicken Alleles {#sec2.5.2}

Protein sequence and PDB ID of chicken alleles (BF2*∗*2101 & BF2*∗*0401) were retrieved from the NCBI database/ (PDB: 4D0C, CAK54661.1 and PDB: 4D0C CAK54660.1) and submitted to Raptor X server (<http://raptorx.uchicago.edu/>) for homology modeling. Chimera software was used to display 3D structure of BF alleles \[[@B29]--[@B32]\].

### 2.5.3. Structure of Predicted Epitopes {#sec2.5.3}

The homology modeling of the MHCI predicted peptides was performed with PEP FOLD3 (<http://bioserv.rpbs.univ-paris-diderot.fr/services/PEP-FOLD3/>) to predict the linear structures from amino acid sequences \[[@B33]--[@B35]\].

2.6. Molecular Docking {#sec2.6}
----------------------

Molecular docking was performed according to peptide-binding groove affinity, between chicken BF alleles (BF2*∗*2101 & BF2*∗*0401) and the proposed peptides from MHCI. Chicken BF alleles were set as receptors and the proposed peptides were set as ligands. Molecular docking technique of 3D structure of BF alleles and 3D modeled epitopes was performed using PatchDock online autodock tools; an automatic server for molecular docking (<https://bioinfo3d.cs.tau.ac.il/PatchDock/>) by submitting PDB of ligands and receptors after homology modeling by Raptor X server and PEP FOLD3 \[[@B36], [@B37]\]. Firedock was used to select the best models \[[@B38]\]. Visualization of the result was performed off-line using UCSF-Chimera visualization tool 1.8. \[[@B29]\].

3. Results and Discussion {#sec3}
=========================

In the vaccine industry, presenting a specific antigen or a host of antigens to the immune system is necessary to increase immunity against viral diseases. The functional component of the vaccine should be able to stimulate the immune system, by using vaccines containing intact inactive components (attenuated viruses; purified immunogenic parts of the pathogen) to trigger immune response \[[@B27], [@B39]\]. It is known that the use of whole viral proteins to induce an immune response is not necessarily but small portions of protein called antigenic determinants or adhesive epitopes can be used to stimulate the desired immunity \[[@B40]\].

The use of bioinformatics analyses is an applicable method for predicting and designing new multiepitope vaccines against animals\' infectious diseases as well as chickens \[[@B17], [@B41], [@B42]\]. This is the first in silico study to design peptide vaccine against avian ILTV through humoral and cell mediated immune responses. The expected epitopes in this study could help in prevention of latent infection caused by the use of attenuated vaccines and developing more effective and trustable prophylactic and therapeutic vaccines than conventional methods.

3.1. Sequences Alignment {#sec3.1}
------------------------

Alignment of all retrieved sequences using ClustalW through BioEdit software showed high conservancy between the aligned sequences. As shown in [Figure 2](#fig2){ref-type="fig"}, the conserved regions were recognized by identity and similarity of amino acid sequences.

3.2. Phylogenetic Evolution {#sec3.2}
---------------------------

Phylogenetic tree was created using (<http://www.phylogeny.fr>). The evolutionary divergence analysis of the enveloped glycoprotein B of the different strains of ILTV is presented in [Figure 3](#fig3){ref-type="fig"}.

3.3. Prediction of B Cell Epitopes {#sec3.3}
----------------------------------

Surface accessibility, hydrophilicity, flexibility, and antigenicity are important B cell antigenic indexes to design peptide vaccine. Investigation of ILTV glycoprotein B using different prediction methods of B cell at the Immune Epitope Database (IEDB) revealed varying threshold for different scales (see [Figure 1](#fig1){ref-type="fig"}). Thirty-one unique linear epitopes with 4 peptides or more in length were predicted using Bepipred Linear Epitope Prediction method depending on binding affinity to B lymphocytes. Analysis of these epitopes for surface accessibility and antigenicity proposed seventeen and thirteen peptides works as surface and antigenic epitopes, respectively (see [Table 2](#tab2){ref-type="table"}). The predicted epitopes were found of high conservancy when tested in aligned sequences. Of these, only eight epitopes successfully covered all the antigenic indexes of B cell prediction tests. The best B cell predicted epitopes that overlap all B cell prediction methods were ~190~*KKLP*~193~, ~386~*YSSTHVRS*~393~, and ~317~*KESV*~320~. The 3D structure of these predicted epitopes is shown in [Figure 4](#fig4){ref-type="fig"}.

3.4. Prediction of T Cell Epitopes {#sec3.4}
----------------------------------

CD8+ and CD4+ T cells have principal role in stimulation of immune response as well as antigen mediated clonal expression of B cell \[[@B14]\]. Several technical problems challenged the design peptide vaccine against ILTV based on T cytotoxic and T helper epitopes prediction, most importantly, the lack of online bioinformatics database for chicken MHC alleles. For this reason human MHC class I alleles (HLA-A and HLA-B) were used in this study as an alternate alleles to investigate the interaction of epitopes with MHCI using epitope prediction software \[[@B43]\]. Studies have shown that the MHC genes in chickens are classified into MHCI associated genes (B-F) and MHCII (B-L) associated B-G genes \[[@B44]\]. The B-F alleles in chicken were found to be similar in stimulation of immune system to mammalian class I homologs especially in presenting the antigen of T-lymphocyte \[[@B45], [@B46]\]. MHC class I molecule in the chicken especially BF2^∗^2101 from the B21 haplotype is highly expressed, leading to strong genetic links with infectious pathogens. In addition, BF2^∗^2101 from the B21 haplotype has principal role in provoking resistance to Marek\'s disease caused by an oncogenic herpesvirus \[[@B43]\], to which ILTV belongs.

### 3.4.1. Prediction of Epitopes Interacted with MHC Class I {#sec3.4.1}

MHC-1 binding prediction tool using IEDB database predicted sixteen epitopes that interacted with the cytotoxic T cell as they strongly linked with multiple alleles. As shown in [Table 3](#tab3){ref-type="table"}, MHCI results expected several CTL epitopes. The top epitope was ~118~*YVFNVTLYY*~126~ which interacted and linked with 16 human alleles, followed by ~335~*VSYKNSYHF*~343~ and ~622~*YLLYEDYTF*~630~ as they linked with 9 human MHCI alleles. The 3D structure of the proposed epitopes is shown in [Figure 5](#fig5){ref-type="fig"}.

### 3.4.2. Prediction of T Helper Cell Epitopes and Interaction with MHC Class II {#sec3.4.2}

The reference strain of glycoprotein B was subjected to different analyzing methods using IEDB MHC-II binding prediction tool based on NN-align with half-maximal inhibitory concentration (IC50) ≤ 1000. The peptide (core) ~301~*FLTDEQFTI*~309~ exhibited high affinity to MHCII alleles due to great binding with 76 MHC-II alleles followed by ~277~*FLEIANYQV*~285~ and ~743~*IASFLSNPF*~751~ as they linked with 67 human alleles ([Table 4](#tab4){ref-type="table"} and [Figure 6](#fig6){ref-type="fig"}).

3.5. Overlapping of T Cell Epitopes Residues in MHC Classes I and II {#sec3.5}
--------------------------------------------------------------------

Twelve epitopes from top five proposed MHC class I were associated with at least to 15 alleles from MHC class II epitopes (see [Table 5](#tab5){ref-type="table"}). It was observed that top proposed epitope from MHCII (*FLTDEQFTI*), which achieved the highest linkages with 76 alleles from MHC class II, was linked with 3 alleles only from MHCI. While the second proposed epitopes (*FLEIANYQV* and*IASFLSNPF*) that bound to 67 MHCII alleles were associated with 2 and 6 alleles from MHC1, respectively. However, of these top epitopes, only four of top MHC1 epitopes and two of best epitopes from MHCII were not linked to any alleles from MHCII and MHCI, respectively.

3.6. Molecular Docking of B-F Alleles and Predicted CTL Epitopes {#sec3.6}
----------------------------------------------------------------

The top ranked CTL proposed epitopes were selected for molecular docking to predict and symbolize the image of real CTL epitopes interaction with chicken alleles. For this purpose, two types of chicken BF alleles (BF2*∗*2101; BF2*∗*0401) were selected. The docked epitopes (~301~*FLTDEQFTI*~309~, ~277~*FLEIANYQV*~285~, and ~743~*IASFLSNPF*~751~) using peptide-binding groove affinity were used to evaluate the ability of predicted epitopes to bind with chicken BF alleles/receptors to chicken alleles BF2 (BF2*∗*2101 and BF2*∗*0401). Results indicated that the docked epitopes achieved strong binding affinity to Chicken BF~2~ alleles based on global energy and attractive VDW in kcal/mol unit. The lowest binding energy (kcal/mol) was selected to predict probable CTL epitopes. Docked ligand epitopes (~118~*YVFNVTLYY*~126~, ~622~*YLLYEDYTF*~630~, and ~335~*VSYKNSYHF*~343~) with BF2 2101 alleles (receptor) showed higher binding affinity which expressed by the lower global energy (-91.78, -89.53, and -66.41, respectively). However, BF 2 0401 allele as a receptor produced less binding affinity with docked ligands (-45.65, -51.56, and -61.68, respectively). These results indicated that the binding affinity of ligands is higher with the receptor BF2*∗*2101 allele compared with the other allele (BF2 0401) which produced less binding affinity. In addition, the docked molecules showed different groove binding site for both BF alleles. [Figure 7](#fig7){ref-type="fig"} presents the 3D structure of chicken BF2 alleles and the proposed binding sites of docked epitopes. The binding energy scores in both BF2 alleles for the suggested epitopes using Patch Dock server for molecular docking are shown in [Table 6](#tab6){ref-type="table"}. The visualization of the binding interactions between chicken BF2 receptor and MHCI epitopes in the structural level was performed using UCSF-Chimera visualization tool 1.8 (see Figures [8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}).

4. Conclusion {#sec4}
=============

Smart computational techniques which provide tremendous predictive and analytical information facilitate the prediction of novel epitopes that may act as a powerful vaccine through immunoinformatic technology.

This is the first in silico study to design peptide vaccine against avian ILTV through humoral and cell mediated immune responses. The expected epitopes in this study could help in prevention of latent infection caused by the use of attenuated vaccines and developing more effective and trustable prophylactic and therapeutic vaccines than conventional methods.

In this study new epitopes were proposed as promising multiepitopes vaccine for ILTV. CTL epitopes were selected as vaccine candidates due to their high binding affinity with different alleles. The result should be supported by designing the peptide vaccine in the lab and through clinical trials.

The authors would like to thank the staff members of College of Veterinary Medicine, University of Bahri, Sudan, for their cooperation and support.

Data Availability
=================

The sequences of envelope glycoprotein B (GB) of ILTV were retrieved from GenBank of National Center for Biotechnology Information (NCBI) (<http://www.ncbi.nlm.nih.gov/protein>) in August 2017. Retrieved strains and their accession numbers and geographical regions were listed in [Table 1](#tab1){ref-type="table"}.

Conflicts of Interest
=====================

The authors declared that they have no conflicts of interest regarding the publication of this paper.

![Prediction of B cell epitopes using (a) Bepipred linear epitope, (b) Emini surface accessibility, and (c) Kolaskar and Tongaonkar Antigenicity methods. Yellow areas above the threshold (red line) are suggested to be a part of B cell epitope, while green areas are not.](ABI2019-1270485.001){#fig1}

![Multiple sequence alignment (MSA) of the retrieved strains using BioEdit software and ClustalW. Dots indicated the conservancy and letters in cubes showed the alteration in amino acid.](ABI2019-1270485.002){#fig2}

![Evolutionary divergence analysis of enveloped glycoprotein B (GB) of different strains of ILTV.](ABI2019-1270485.003){#fig3}

![(a) The reference glycoprotein B of ILTV. (b) The position of proposed B cell epitopes in the 3D structure of reference glycoprotein B of ILTV.](ABI2019-1270485.004){#fig4}

![The 3D structure of reference glycoprotein B of ILTV and the position of proposed cytotoxic T cell epitopes suggested to interact with MHC-I virus illustrated by UCSF-Chimera visualization tool.](ABI2019-1270485.005){#fig5}

![3D structure of reference glycoprotein B of ILTV and the position of proposed helper T cell epitopes suggested to interact with MHC-II virus illustrated by UCSF-Chimera visualization tool.](ABI2019-1270485.006){#fig6}

![The 3D structure of BF~2~ alleles of chicken using Chimera visualization tool. Red circle indicated the binding site of epitopes.](ABI2019-1270485.007){#fig7}

![Visualization of PatchDock Molecular docking of MHC-I proposed epitopes and chicken BF2 alleles receptors using UCSF-Chimera visualization tool. Receptors (BF alleles) are represented by pink colour while CTL epitopes are represented by green one.](ABI2019-1270485.008){#fig8}

![Visualization of PatchDock Molecular docking of MHCI proposed epitopes and chicken BF2 alleles receptors using UCSF-Chimera visualization tool. Receptors (BF alleles) are represented by rounded ribbon structure hot pink colour while CTL epitopes are represented by green one.](ABI2019-1270485.009){#fig9}

###### 

Retrieved strains of ILTV with their date of collection, accession numbers, and geographical regions.

  Accession No     country     Year   Accession No   country     Year
  ---------------- ----------- ------ -------------- ----------- ------
  YP_182356.1*∗*   USA         2005   AEW67850.1     USA         2012
  AFV79628.1       China       2011   AEW67771.1     USA         2011
  ABX59525.1       ＇＇USA     2007   AEB97319.1     Australia   2010
  ABX59524.1       USA         2007   ABX59533.1     USA         2007
  ANB43607.1       Russia      2000   ABX59532.1     USA         2007
  ANF04484.1       Australia   2015   ABX59531.1     USA         2007
  ANN24991.1       USA         2017   ABX59530.1     USA         2007
  ANN24921.1       USA         2016   ABX59529.1     USA         2007
  AJR27653.1       Italy       2007   ABX59528.1     USA         2007
  AJR27811.1       Italy       1980   ABX59527.1     USA         2007
  AJR27732.1       Italy       2011   ABX59526.1     USA         2007
  AJR27574.1       Italy       2015   ABX59523.1     USA         2007
  AJR27495.1       Italy       2015   ABX59522.1     USA         2007
  AER28131.1       Australia   2011   ABX59521.1     USA         2007
  AER28052.1       Australia   2011   ABX59520.1     USA         2007
  AGN48336.1       China       2012   ABX59519.1     USA         2007
  AGN48256.1       China       2012   ABX59518.1     USA         2007
  AGN48178.1       China       2009   ABX59517.1     USA         2007
  AGC23137.1       Australia   1970   ABX59516.1     USA         2007
  AGC23058.1       Australia   1999   ABX59515.1     USA         2007
  AFN02008.1       Australia   2011   ABX59514.1     USA         2007
  AFN01929.1       Australia   2011   ABX59513.1     USA         2007

*∗*Refseq of ILTV envelope glycoprotein B.

###### 

List of B cell epitopes predicted by different B cell scales.

  ----------------------------------------------------------------------------------------------------
  No.   Peptide                                    Start   End   Length   Emini 1000   Antigenicity\
                                                                                       1.027
  ----- ------------------------------------------ ------- ----- -------- ------------ ---------------
  1     QFTI                                       306     309   4        0.514        1.042

  2     GQPVS                                      518     522   5        0.678        1.07

  3     KLNPNS                                     506     511   6        1.715        0.968

  4     NASEIE                                     635     640   6        0.888        0.951

  5     LGEVGKA                                    718     724   7        0.303        1.032

  6     DAMEEKESV                                  312     320   9        1.355        0.959

  7     KESV*∗*                                    317     320   4        1.168        1.044

  8     EVPEAVRVS                                  328     336   9        0.395        0.959

  9     VIRGDRGDA                                  697     705   9        0.433        0.981

  10    PQITNEYVTR                                 141     150   10       1.433        1.009

  11    EYVTR*∗*                                   146     150   5        1.465        1.035

  12    TFSSGKQPFN                                 351     360   10       0.957        0.977

  13    RSGECSSKATY                                163     173   11       0.837        1.01

  14    YDNDEAEKKLP                                183     193   11       4.592        0.964

  15    KKLP*∗*                                    190     193   4        1.729        1.044

  16    KDEQKARRQKA                                834     844   11       11.486       0.946

  17    EAIGSGAPKEPQI                              58      70    13       0.374        0.997

  18    HCHRHADSTNMTE                              93      105   13       0.786        0.986

  19    CSSPTGASVARLAQ                             77      90    14       0.103        1.072

  20    YSSTHVRSGDIEYYL                            386     400   15       0.537        1.052

  21    YSSTHVRS*∗*                                386     393   8        1.152        1.058

  22    NFTKRHQTLGYRTSTS                           211     226   16       2.246        0.976

  23    RHQTLGY*∗*                                 215     221   7        1.232        1.027

  24    SSSPESQFSANSTENH                           569     584   16       1.851        0.973

  25    VYTREELRDTGTLNYD                           663     678   16       1.703        0.985

  26    VYTREEL*∗*                                 663     669   7        1.176        1.04

  27    VRDLETGQIRPPKKRNFL                         285     302   18       1.191        1.001

  28    QIRPP*∗*                                   292     296   5        1.463        1.034

  29    FGMATGDTVEISPFYTKNTTGPRRHSV                245     271   27       0.185        0.991

  30    EEAQRQNHLPRGRERRQAAGRRTASLQSGPQGDRITTHSS   423     462   40       8.232        0.969

  31    QNHLP*∗*                                   428     432   5        1.243        1.042
  ----------------------------------------------------------------------------------------------------

*∗*Shortened peptide that has high score in both Emini and Kolaskar.

###### 

Position of most promising epitopes in the glycoprotein B of ILTV that bind with high affinity with the human MHC class I alleles.

  Peptide         Start    End   Allele          ic50
  --------------- -------- ----- --------------- --------
  MLICVCVAI       16       24    HLA-A*∗*02:01   19.5
  HLA-A*∗*02:06   27.85                          
  HLA-A*∗*32:01   181.4                          
  HLA-A*∗*68:02   50.12                          
  HLA-B*∗*15:01   209.67                         
                                                 
  YVFNVTLYY*∗*    118      126   HLA-A*∗*01:01   52.47
  HLA-A*∗*03:01   31.62                          
  HLA-A*∗*11:01   8.01                           
  HLA-A*∗*25:01   245.85                         
  HLA-A*∗*26:01   7.03                           
  HLA-A*∗*29:02   2.26                           
  HLA-A*∗*30:02   29.28                          
  HLA-A*∗*68:01   10.69                          
  HLA-B*∗*15:01   41.17                          
  HLA-B*∗*35:01   8.03                           
  HLA-B*∗*46:01   109.43                         
  HLA-B*∗*58:01   103.63                         
                                                 
  LYYKHITTV       124      132   HLA-A*∗*23:01   176.88
  HLA-A*∗*24:02   255.62                         
  HLA-C*∗*06:02   228.43                         
  HLA-C*∗*07:01   281.81                         
  HLA-C*∗*12:03   40.39                          
  HLA-C*∗*14:02   20.88                          
                                                 
  TTVTTWALF       130      138   HLA-A*∗*23:01   186.44
  HLA-A*∗*24:02   291.18                         
  HLA-A*∗*26:01   43.17                          
  HLA-A*∗*29:02   140.22                         
  HLA-B*∗*57:01   135.77                         
  HLA-B*∗*58:01   126.76                         
                                                 
  MATGDTVEI       247      255   HLA-A*∗*02:06   298.31
  HLA-A*∗*68:02   27.18                          
  HLA-B*∗*35:01   70.95                          
  HLA-B*∗*53:01   91.98                          
  HLA-C*∗*03:03   22.67                          
  HLA-C*∗*12:03   107.28                         
                                                 
  DTVEISPFY       251      259   HLA-A*∗*25:01   219.57
  HLA-A*∗*26:01   2.97                           
  HLA-A*∗*29:02   28.64                          
  HLA-A*∗*68:01   41.47                          
  HLA-B*∗*35:01   269.44                         
                                                 
  YRFLEIANY       275      283   HLA-B*∗*27:05   183.15
  HLA-C*∗*06:02   157.29                         
  HLA-C*∗*07:01   169.97                         
  HLA-C*∗*07:02   281.69                         
  HLA-C*∗*12:03   252.46                         
  HLA-C*∗*14:02   290.98                         
                                                 
  VSYKNSYHF*∗*    335      343   HLA-A*∗*23:01   26.91
  HLA-A*∗*24:02   283.17                         
  HLA-A*∗*32:01   256.64                         
  HLA-B*∗*15:01   45.93                          
  HLA-B*∗*57:01   69.13                          
  HLA-B*∗*58:01   18.43                          
  HLA-C*∗*03:03   254.73                         
  HLA-C*∗*12:03   111.22                         
  HLA-C*∗*15:02   261.59                         
                                                 
  YKNSYHFSL       337      345   HLA-B*∗*08:01   212.76
  HLA-B*∗*39:01   7.84                           
  HLA-C*∗*03:03   17.48                          
  HLA-C*∗*07:02   41.18                          
  HLA-C*∗*14:02   249.85                         
                                                 
  HVRSGDIEY       390      398   HLA-A*∗*29:02   250.74
  HLA-A*∗*30:01   43.1                           
  HLA-B*∗*15:01   199.81                         
  HLA-B*∗*15:02   295.16                         
  HLA-B*∗*35:01   9.19                           
                                                 
  MSHGLAEMY       413      421   HLA-A*∗*29:02   33.03
  HLA-A*∗*30:02   95.04                          
  HLA-B*∗*15:01   263.61                         
  HLA-B*∗*35:01   49.68                          
  HLA-B*∗*57:01   132.85                         
  HLA-B*∗*58:01   228.7                          
                                                 
  FAYDKIQAH       470      478   HLA-B*∗*35:01   56.25
  HLA-B*∗*46:01   189.03                         
  HLA-C*∗*03:03   5.42                           
  HLA-C*∗*12:03   9.1                            
  HLA-C*∗*14:02   231.14                         
                                                 
  YLLYEDYTF*∗*    622      630   HLA-A*∗*02:01   215.94
  HLA-A*∗*02:06   77.51                          
  HLA-A*∗*23:01   31.7                           
  HLA-A*∗*24:02   237.46                         
  HLA-A*∗*29:02   60.11                          
  HLA-A*∗*32:01   132.77                         
  HLA-B*∗*15:01   163.87                         
  HLA-B*∗*15:02   48.14                          
  HLA-B*∗*35:01   62.28                          
                                                 
  VVMTAAAAV       728      736   HLA-A*∗*02:01   80.99
  HLA-A*∗*02:06   10.14                          
  HLA-A*∗*68:02   42.19                          
  HLA-C*∗*14:02   60.62                          
  HLA-C*∗*15:02   231.69                         
                                                 
  IASFLSNPF       743      751   HLA-A*∗*32:01   81.65
  HLA-B*∗*15:01   94.19                          
  HLA-B*∗*35:01   11.95                          
  HLA-B*∗*58:01   219.61                         
  HLA-C*∗*03:03   83.79                          
  HLA-C*∗*12:03   189.81                         
                                                 
  FLSNPFAAL       746      754   HLA-A*∗*02:01   16.28
  HLA-A*∗*02:06   8.88                           
  HLA-A*∗*68:02   172.75                         
  HLA-B*∗*15:01   128.57                         
  HLA-B*∗*15:02   136.86                         
  HLA-C*∗*03:03   3.25                           
  HLA-C*∗*12:03   140.95                         
  HLA-C*∗*14:02   85.38                          
                                                 
  KSNPVQVLF       778      786   HLA-A*∗*32:01   76.58
  HLA-B*∗*15:01   283.12                         
  HLA-B*∗*57:01   19.71                          
  HLA-B*∗*58:01   2.62                           
  HLA-C*∗*15:02   155.84                         

*∗*Proposed peptides.

###### 

List of best six epitopes that bind with high affinity with the human MHC class II alleles.

  ----------------------------------------------------------------------------------------------------------------------------------
  Core Sequence                   Peptide Sequence   Start   End                             Allele                          IC50
  ------------------------------- ------------------ ------- ------------------------------- ------------------------------- -------
  LLRSTVSKA                       LPLVPSLLRSTVSKA    192     206                             HLA-DQA1*∗*01:02/DQB1*∗*06:02   824.7

  HLA-DRB1*∗*01:01                99.4                                                                                       

  HLA-DRB1*∗*03:01                421.6                                                                                      

  HLA-DRB1*∗*04:01                300.9                                                                                      

  HLA-DRB1*∗*04:05                768.9                                                                                      

  HLA-DRB1*∗*07:01                155.6                                                                                      

  HLA-DRB1*∗*08:02                143.9                                                                                      

  HLA-DRB1*∗*09:01                783.8                                                                                      

  HLA-DRB1*∗*15:01                888.9                                                                                      

  PLVPSLLRSTVSKAF                 193                207     HLA-DPA1*∗*02:01/DPB1*∗*01:01   436                             

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   538.2                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   413.8                                                                                      

  HLA-DRB1*∗*01:01                42.1                                                                                       

  HLA-DRB1*∗*03:01                123.5                                                                                      

  HLA-DRB1*∗*04:01                185.5                                                                                      

  HLA-DRB1*∗*04:04                166.7                                                                                      

  HLA-DRB1*∗*04:05                478                                                                                        

  HLA-DRB1*∗*08:02                103                                                                                        

  HLA-DRB1*∗*09:01                394.9                                                                                      

  HLA-DRB1*∗*13:02                774.7                                                                                      

  HLA-DRB1*∗*15:01                978                                                                                        

  LVPSLLRSTVSKAFH                 194                208     HLA-DPA1*∗*02:01/DPB1*∗*01:01   464.3                           

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   457.4                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   378.5                                                                                      

  HLA-DRB1*∗*01:01                26.9                                                                                       

  HLA-DRB1*∗*03:01                57.1                                                                                       

  HLA-DRB1*∗*04:01                147.6                                                                                      

  HLA-DRB1*∗*04:05                360                                                                                        

  HLA-DRB1*∗*08:02                71.5                                                                                       

  HLA-DRB1*∗*09:01                336.5                                                                                      

  HLA-DRB1*∗*11:01                148.8                                                                                      

  HLA-DRB1*∗*13:02                652.3                                                                                      

  HLA-DRB1*∗*15:01                824.6                                                                                      

  VPSLLRSTVSKAFHT                 195                209     HLA-DPA1*∗*02:01/DPB1*∗*01:01   682.2                           

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   397.2                                                                                      

  HLA-DRB1*∗*01:01                18                                                                                         

  HLA-DRB1*∗*03:01                32.8                                                                                       

  HLA-DRB1*∗*04:01                108.8                                                                                      

  HLA-DRB1*∗*04:05                303.1                                                                                      

  HLA-DRB1*∗*08:02                52                                                                                         

  HLA-DRB1*∗*09:01                219.9                                                                                      

  HLA-DRB1*∗*13:02                568.1                                                                                      

  HLA-DRB1*∗*15:01                745                                                                                        

  PSLLRSTVSKAFHTT                 196                210     HLA-DPA1*∗*02:01/DPB1*∗*01:01   871.8                           

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   506.4                                                                                      

  HLA-DRB1*∗*01:01                26.3                                                                                       

  HLA-DRB1*∗*03:01                49.1                                                                                       

  HLA-DRB1*∗*04:01                126.7                                                                                      

  HLA-DRB1*∗*04:04                178.1                                                                                      

  HLA-DRB1*∗*04:05                369.2                                                                                      

  HLA-DRB1*∗*08:02                61.5                                                                                       

  HLA-DRB1*∗*15:01                809.3                                                                                      

  SLLRSTVSKAFHTTN                 197                211     HLA-DQA1*∗*01:02/DQB1*∗*06:02   609.2                           

  HLA-DRB1*∗*01:01                36.6                                                                                       

  HLA-DRB1*∗*03:01                89.2                                                                                       

  HLA-DRB1*∗*04:01                130.9                                                                                      

  HLA-DRB1*∗*04:05                467.4                                                                                      

  HLA-DRB1*∗*08:02                75.6                                                                                       

  LLRSTVSKAFHTTNF                 198                212     HLA-DQA1*∗*01:02/DQB1*∗*06:02   836.1                           

  HLA-DRB1*∗*03:01                218.7                                                                                      

  HLA-DRB1*∗*04:01                184.1                                                                                      

  HLA-DRB1*∗*04:04                384.5                                                                                      

  HLA-DRB1*∗*04:05                643.2                                                                                      

  HLA-DRB1*∗*08:02                106                                                                                        

                                                                                                                             

  FLEIANYQV                       VYRDYRFLEIANYQV\   271\    285\                            HLA-DRB1*∗*07:01                9.1

  HLA-DRB1*∗*08:02                752                                                                                        

  HLA-DRB1*∗*13:02                288.3                                                                                      

  HLA-DRB5*∗*01:01                67.4                                                                                       

  YRDYRFLEIANYQVR\                272\               286\    HLA-DRB1*∗*07:01                10.9                            

  HLA-DRB1*∗*08:02                565                                                                                        

  HLA-DRB1*∗*13:02                237.5                                                                                      

  HLA-DRB5*∗*01:01                29.8                                                                                       

  RDYRFLEIANYQVRD                 273                287     HLA-DPA1*∗*01/DPB1*∗*04:01      284.1                           

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   90.8                                                                                       

  HLA-DRB1*∗*01:01                8.9                                                                                        

  HLA-DRB1*∗*04:01                41.8                                                                                       

  HLA-DRB1*∗*07:01                15.6                                                                                       

  HLA-DRB1*∗*08:02                585.2                                                                                      

  HLA-DRB1*∗*11:01                54.1                                                                                       

  HLA-DRB1*∗*13:02                216.2                                                                                      

  HLA-DRB3*∗*01:01                875                                                                                        

  HLA-DRB5*∗*01:01                27.2                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   218.5                                                                                      

  HLA-DQA1*∗*01:01/DQB1*∗*05:01   637.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   331.2                                                                                      

  HLA-DRB1*∗*04:04                81.1                                                                                       

  HLA-DRB1*∗*04:05                32.1                                                                                       

  HLA-DRB1*∗*09:01                273.4                                                                                      

  DYRFLEIANYQVRDL                 274                288     HLA-DPA1*∗*01/DPB1*∗*04:01      475                             

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   72.5                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   42.9                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   294.4                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   462.5                                                                                      

  HLA-DRB1*∗*01:01                8.3                                                                                        

  HLA-DRB1*∗*04:01                58.2                                                                                       

  HLA-DRB1*∗*04:05                39.5                                                                                       

  HLA-DRB1*∗*07:01                15.9                                                                                       

  HLA-DRB1*∗*08:02                704.3                                                                                      

  HLA-DRB1*∗*11:01                43.5                                                                                       

  HLA-DRB1*∗*13:02                190.3                                                                                      

  HLA-DRB3*∗*01:01                979.2                                                                                      

  HLA-DRB5*∗*01:01                18.3                                                                                       

  RFLEIANYQVRDLET                 276                290     HLA-DPA1*∗*01/DPB1*∗*04:01      594                             

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   113.7                                                                                      

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   66                                                                                         

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   726.4                                                                                      

  HLA-DRB1*∗*01:01                15.5                                                                                       

  HLA-DRB1*∗*04:01                261.2                                                                                      

  HLA-DRB1*∗*04:04                174.2                                                                                      

  HLA-DRB1*∗*04:05                174.3                                                                                      

  HLA-DRB1*∗*07:01                31                                                                                         

  HLA-DRB1*∗*09:01                931.6                                                                                      

  HLA-DRB1*∗*11:01                140.6                                                                                      

  HLA-DRB1*∗*13:02                486.4                                                                                      

  HLA-DRB5*∗*01:01                39                                                                                         

  FLEIANYQVRDLETG                 277                291     HLA-DPA1*∗*01:03/DPB1*∗*02:01   336.8                           

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   146.9                                                                                      

  HLA-DRB1*∗*01:01                28.9                                                                                       

  HLA-DRB1*∗*04:04                273.3                                                                                      

  HLA-DRB1*∗*04:05                325.2                                                                                      

  HLA-DRB1*∗*07:01                57.2                                                                                       

  HLA-DRB1*∗*11:01                340.9                                                                                      

  HLA-DRB1*∗*13:02                852.9                                                                                      

  HLA-DRB5*∗*01:01                101.7                                                                                      

                                                                                                                             

  FLTDEQFTI                       PPKKRNFLTDEQFTI    295     309                             HLA-DPA1*∗*01/DPB1*∗*04:01      246.4

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   35.5                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   93.6                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   541                                                                                        

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   506.6                                                                                      

  HLA-DRB1*∗*03:01                76.1                                                                                       

  HLA-DRB1*∗*04:01                198.7                                                                                      

  HLA-DRB1*∗*04:05                274.9                                                                                      

  HLA-DRB1*∗*07:01                98.6                                                                                       

  HLA-DRB3*∗*01:01                4.9                                                                                        

  HLA-DRB5*∗*01:01                948.8                                                                                      

  PKKRNFLTDEQFTIG                 296                310     HLA-DPA1*∗*01/DPB1*∗*04:01      172.7                           

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   24.5                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   82.3                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   475.5                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   341.5                                                                                      

  HLA-DRB1*∗*01:01                850.7                                                                                      

  HLA-DRB1*∗*03:01                59.9                                                                                       

  HLA-DRB1*∗*04:01                136.1                                                                                      

  HLA-DRB1*∗*04:04                869.9                                                                                      

  HLA-DRB1*∗*04:05                325                                                                                        

  HLA-DRB1*∗*07:01                162                                                                                        

  HLA-DRB3*∗*01:01                4.8                                                                                        

  HLA-DRB5*∗*01:01                769                                                                                        

  KKRNFLTDEQFTIGW                 297                311     HLA-DPA1*∗*01/DPB1*∗*04:01      123                             

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   20.1                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   66.4                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   394.6                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   199                                                                                        

  HLA-DRB1*∗*01:01                342.9                                                                                      

  HLA-DRB1*∗*03:01                37.7                                                                                       

  HLA-DRB1*∗*04:01                103.7                                                                                      

  HLA-DRB1*∗*04:04                805.9                                                                                      

  HLA-DRB1*∗*04:05                330.3                                                                                      

  HLA-DRB1*∗*07:01                203.9                                                                                      

  HLA-DRB3*∗*01:01                4.6                                                                                        

  HLA-DRB5*∗*01:01                527                                                                                        

  KRNFLTDEQFTIGWD                 298                312     HLA-DPA1*∗*01/DPB1*∗*04:01      110.8                           

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   21.6                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   65                                                                                         

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   405.2                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   148.2                                                                                      

  HLA-DRB1*∗*01:01                354.3                                                                                      

  HLA-DRB1*∗*03:01                31.7                                                                                       

  HLA-DRB1*∗*04:01                98.2                                                                                       

  HLA-DRB1*∗*04:05                398.7                                                                                      

  HLA-DRB1*∗*07:01                325.7                                                                                      

  HLA-DRB3*∗*01:01                4.4                                                                                        

  HLA-DRB5*∗*01:01                505.9                                                                                      

  RNFLTDEQFTIGWDA                 299                313     HLA-DPA1*∗*01/DPB1*∗*04:01      115.3                           

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   26.7                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   88.5                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*05:01   532.9                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   182.5                                                                                      

  HLA-DRB1*∗*01:01                687.7                                                                                      

  HLA-DRB1*∗*03:01                64.7                                                                                       

  HLA-DRB1*∗*04:01                178.3                                                                                      

  HLA-DRB1*∗*04:05                700.1                                                                                      

  HLA-DRB3*∗*01:01                5.9                                                                                        

  HLA-DRB5*∗*01:01                948.3                                                                                      

  NFLTDEQFTIGWDAM                 300                314     HLA-DPA1*∗*01/DPB1*∗*04:01      244                             

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   44.6                                                                                       

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   173.3                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   250.2                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*02:01   475.1                                                                                      

  HLA-DRB1*∗*03:01                164.3                                                                                      

  HLA-DRB1*∗*04:01                278.3                                                                                      

  HLA-DRB3*∗*01:01                9                                                                                          

  FLTDEQFTIGWDAME                 301                315     HLA-DPA1*∗*01/DPB1*∗*04:01      640                             

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   154.8                                                                                      

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   395.6                                                                                      

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   437.8                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*02:01   459.5                                                                                      

  HLA-DRB1*∗*03:01                433.9                                                                                      

  HLA-DRB1*∗*04:01                271.4                                                                                      

  HLA-DRB3*∗*01:01                15.5                                                                                       

                                                                                                                             

  LLGDIVAVS                       QPVSARLLGDIVAVS    519     533                             HLA-DPA1*∗*02:01/DPB1*∗*01:01   922.5

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   822.3                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   726                                                                                        

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   42.2                                                                                       

  HLA-DRB1*∗*04:01                494.1                                                                                      

  HLA-DRB1*∗*08:02                914.5                                                                                      

  HLA-DRB3*∗*01:01                211.5                                                                                      

  PVSARLLGDIVAVSK                 520                534     HLA-DPA1*∗*02:01/DPB1*∗*01:01   752.7                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   853.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   715.4                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   34                                                                                         

  HLA-DRB1*∗*03:01                380.3                                                                                      

  HLA-DRB1*∗*04:01                298                                                                                        

  HLA-DRB1*∗*04:05                458.8                                                                                      

  HLA-DRB1*∗*08:02                571.8                                                                                      

  HLA-DRB3*∗*01:01                196.5                                                                                      

  VSARLLGDIVAVSKC                 521                535     HLA-DPA1*∗*02:01/DPB1*∗*01:01   723.1                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   733.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   502.8                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   29.9                                                                                       

  HLA-DRB1*∗*03:01                214.3                                                                                      

  HLA-DRB1*∗*04:01                237                                                                                        

  HLA-DRB1*∗*04:05                429.4                                                                                      

  HLA-DRB1*∗*08:02                541.8                                                                                      

  HLA-DRB3*∗*01:01                172.3                                                                                      

  SARLLGDIVAVSKCI                 522                536     HLA-DPA1*∗*02:01/DPB1*∗*01:01   677.6                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   650.5                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   555.2                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   26.4                                                                                       

  HLA-DRB1*∗*01:01                175.3                                                                                      

  HLA-DRB1*∗*03:01                124.9                                                                                      

  HLA-DRB1*∗*04:01                187.9                                                                                      

  HLA-DRB1*∗*04:05                396.3                                                                                      

  HLA-DRB1*∗*08:02                396.7                                                                                      

  HLA-DRB3*∗*01:01                143.4                                                                                      

  ARLLGDIVAVSKCIE                 523                537     HLA-DPA1*∗*02:01/DPB1*∗*01:01   791.2                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   787.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   590.2                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   31.5                                                                                       

  HLA-DRB1*∗*01:01                270.9                                                                                      

  HLA-DRB1*∗*03:01                199.3                                                                                      

  HLA-DRB1*∗*04:01                255.3                                                                                      

  HLA-DRB1*∗*04:05                643.6                                                                                      

  HLA-DRB1*∗*08:02                360.5                                                                                      

  HLA-DRB3*∗*01:01                379.2                                                                                      

  RLLGDIVAVSKCIEI                 524                538     HLA-DPA1*∗*02:01/DPB1*∗*01:01   807.2                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   911.1                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   621.6                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   35.4                                                                                       

  HLA-DRB1*∗*03:01                347.3                                                                                      

  HLA-DRB1*∗*04:01                375.6                                                                                      

  HLA-DRB1*∗*04:05                977.9                                                                                      

  HLA-DRB1*∗*08:02                414.9                                                                                      

  HLA-DRB3*∗*01:01                974.2                                                                                      

  LLGDIVAVSKCIEIP                 525                539     HLA-DPA1*∗*02:01/DPB1*∗*01:01   941                             

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   748.6                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   37.1                                                                                       

  HLA-DRB1*∗*03:01                688                                                                                        

  HLA-DRB1*∗*04:01                848.5                                                                                      

  HLA-DRB1*∗*08:02                521                                                                                        

                                                                                                                             

  IASFLSNPF                       ISTVSGIASFLSNPF    737     751                             HLA-DPA1*∗*02:01/DPB1*∗*01:01   264.9

  HLA-DQA1*∗*05:01/DQB1*∗*02:01   384.2                                                                                      

  HLA-DRB1*∗*04:01                53.5                                                                                       

  HLA-DRB1*∗*04:04                92.5                                                                                       

  HLA-DRB1*∗*04:05                16.2                                                                                       

  HLA-DRB1*∗*07:01                25                                                                                         

  HLA-DRB1*∗*09:01                104.9                                                                                      

  HLA-DRB1*∗*15:01                24.4                                                                                       

  HLA-DRB5*∗*01:01                103.5                                                                                      

  STVSGIASFLSNPFA                 738                752     HLA-DPA1*∗*01/DPB1*∗*04:01      559.3                           

  HLA-DPA1*∗*01:03/DPB1*∗*02:01   320.6                                                                                      

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   240.5                                                                                      

  HLA-DQA1*∗*01:01/DQB1*∗*05:01   976.4                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*02:01   474.6                                                                                      

  HLA-DRB1*∗*01:01                101.3                                                                                      

  HLA-DRB1*∗*04:01                41.8                                                                                       

  HLA-DRB1*∗*04:05                15.5                                                                                       

  HLA-DRB1*∗*07:01                31.3                                                                                       

  HLA-DRB1*∗*08:02                589.8                                                                                      

  HLA-DRB1*∗*09:01                74.3                                                                                       

  HLA-DRB1*∗*15:01                18.9                                                                                       

  HLA-DRB5*∗*01:01                77.6                                                                                       

  TVSGIASFLSNPFAA                 739                753     HLA-DPA1*∗*01:03/DPB1*∗*02:01   179.9                           

  HLA-DPA1*∗*02:01/DPB1*∗*01:01   219.5                                                                                      

  HLA-DQA1*∗*01:01/DQB1*∗*05:01   915.8                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*02:01   611.8                                                                                      

  HLA-DRB1*∗*01:01                40.6                                                                                       

  HLA-DRB1*∗*04:01                27.7                                                                                       

  HLA-DRB1*∗*04:05                15.5                                                                                       

  HLA-DRB1*∗*07:01                44                                                                                         

  HLA-DRB1*∗*08:02                538.8                                                                                      

  HLA-DRB1*∗*09:01                72.2                                                                                       

  HLA-DRB1*∗*15:01                15.9                                                                                       

  HLA-DRB5*∗*01:01                57.1                                                                                       

  VSGIASFLSNPFAAL                 740                754     HLA-DQA1*∗*01:01/DQB1*∗*05:01   710                             

  HLA-DQA1*∗*05:01/DQB1*∗*02:01   755.5                                                                                      

  HLA-DRB1*∗*01:01                14.2                                                                                       

  HLA-DRB1*∗*03:01                427.9                                                                                      

  HLA-DRB1*∗*04:01                22                                                                                         

  HLA-DRB1*∗*04:05                14.6                                                                                       

  HLA-DRB1*∗*07:01                43.3                                                                                       

  HLA-DRB1*∗*08:02                486.4                                                                                      

  HLA-DRB1*∗*09:01                52.2                                                                                       

  HLA-DRB1*∗*11:01                377.7                                                                                      

  HLA-DRB1*∗*15:01                12.8                                                                                       

  HLA-DRB5*∗*01:01                29.4                                                                                       

  SGIASFLSNPFAALG                 741                755     HLA-DQA1*∗*01:01/DQB1*∗*05:01   936.1                           

  HLA-DRB1*∗*03:01                629.7                                                                                      

  HLA-DRB1*∗*04:01                27.6                                                                                       

  HLA-DRB1*∗*04:05                18                                                                                         

  HLA-DRB1*∗*07:01                67.9                                                                                       

  HLA-DRB1*∗*08:02                582.5                                                                                      

  HLA-DRB1*∗*09:01                56.2                                                                                       

  HLA-DRB1*∗*15:01                14.6                                                                                       

  HLA-DRB5*∗*01:01                50.2                                                                                       

  GIASFLSNPFAALGI                 742                756     HLA-DRB1*∗*01:01                27.1                            

  HLA-DRB1*∗*04:01                38.1                                                                                       

  HLA-DRB1*∗*04:05                27.3                                                                                       

  HLA-DRB1*∗*08:02                594.2                                                                                      

  HLA-DRB1*∗*09:01                58.6                                                                                       

  HLA-DRB1*∗*15:01                17.4                                                                                       

  HLA-DRB5*∗*01:01                73.5                                                                                       

  IASFLSNPFAALGIG                 743                757     HLA-DRB1*∗*04:01                67                              

  HLA-DRB1*∗*04:05                41.9                                                                                       

  HLA-DRB1*∗*15:01                28.6                                                                                       

  HLA-DRB4*∗*01:01                735.5                                                                                      

  HLA-DRB5*∗*01:01                119.8                                                                                      

                                                                                                                             

  LLGDIVAVS                       QPVSARLLGDIVAVS    519     533                             HLA-DPA1*∗*02:01/DPB1*∗*01:01   922.5

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   822.3                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   726                                                                                        

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   42.2                                                                                       

  HLA-DRB1*∗*04:01                494.1                                                                                      

  HLA-DRB1*∗*08:02                914.5                                                                                      

  HLA-DRB3*∗*01:01                211.5                                                                                      

  PVSARLLGDIVAVSK                 520                534     HLA-DPA1*∗*02:01/DPB1*∗*01:01   752.7                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   853.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   715.4                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   34                                                                                         

  HLA-DRB1*∗*03:01                380.3                                                                                      

  HLA-DRB1*∗*04:01                298                                                                                        

  HLA-DRB1*∗*04:05                458.8                                                                                      

  HLA-DRB1*∗*08:02                571.8                                                                                      

  HLA-DRB3*∗*01:01                196.5                                                                                      

  VSARLLGDIVAVSKC                 521                535     HLA-DPA1*∗*02:01/DPB1*∗*01:01   723.1                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   733.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   502.8                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   29.9                                                                                       

  HLA-DRB1*∗*03:01                214.3                                                                                      

  HLA-DRB1*∗*04:01                237                                                                                        

  HLA-DRB1*∗*04:05                429.4                                                                                      

  HLA-DRB1*∗*08:02                541.8                                                                                      

  HLA-DRB3*∗*01:01                172.3                                                                                      

  SARLLGDIVAVSKCI                 522                536     HLA-DPA1*∗*02:01/DPB1*∗*01:01   677.6                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   650.5                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   555.2                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   26.4                                                                                       

  HLA-DRB1*∗*01:01                175.3                                                                                      

  HLA-DRB1*∗*03:01                124.9                                                                                      

  HLA-DRB1*∗*04:01                187.9                                                                                      

  HLA-DRB1*∗*04:05                396.3                                                                                      

  HLA-DRB1*∗*08:02                396.7                                                                                      

  HLA-DRB3*∗*01:01                143.4                                                                                      

  ARLLGDIVAVSKCIE                 523                537     HLA-DPA1*∗*02:01/DPB1*∗*01:01   791.2                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   787.4                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   590.2                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   31.5                                                                                       

  HLA-DRB1*∗*01:01                270.9                                                                                      

  HLA-DRB1*∗*03:01                199.3                                                                                      

  HLA-DRB1*∗*04:01                255.3                                                                                      

  HLA-DRB1*∗*04:05                643.6                                                                                      

  HLA-DRB1*∗*08:02                360.5                                                                                      

  HLA-DRB3*∗*01:01                379.2                                                                                      

  RLLGDIVAVSKCIEI                 524                538     HLA-DPA1*∗*02:01/DPB1*∗*01:01   807.2                           

  HLA-DPA1*∗*03:01/DPB1*∗*04:02   911.1                                                                                      

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   621.6                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   35.4                                                                                       

  HLA-DRB1*∗*03:01                347.3                                                                                      

  HLA-DRB1*∗*04:01                375.6                                                                                      

  HLA-DRB1*∗*04:05                977.9                                                                                      

  HLA-DRB1*∗*08:02                414.9                                                                                      

  HLA-DRB3*∗*01:01                974.2                                                                                      

  LLGDIVAVSKCIEIP                 525                539     HLA-DPA1*∗*02:01/DPB1*∗*01:01   941                             

  HLA-DQA1*∗*01:02/DQB1*∗*06:02   748.6                                                                                      

  HLA-DQA1*∗*05:01/DQB1*∗*03:01   37.1                                                                                       

  HLA-DRB1*∗*03:01                688                                                                                        

  HLA-DRB1*∗*04:01                848.5                                                                                      

  HLA-DRB1*∗*08:02                521                                                                                        
  ----------------------------------------------------------------------------------------------------------------------------------

*∗*Inhibitory concentration needed for binding MHC II to the IEDB NN-align method; the lower value is better.

###### 

Comparison between the numbers of alleles linked with top proposed epitopes in MHCI and MHCII.

  Peptide       MHCI    MHCII
  ------------- ------- --------
  *MLICVCVAI*   5       0
  *YVFNVTLYY*   12*∗*   49
  *LYYKHITTV*   6       21
  *TTVTTWALF*   6       16
  *MATGDTVEI*   6       0
  *DTVEISPFY*   5       5
  *YRFLEIANY*   6       49
  *VSYKNSYHF*   9*∗*    15
  *YKNSYHFSL*   5       45
  *HVRSGDIEY*   5       0
  *MSHGLAEMY*   6       22
  *VVMTAAAAV*   5       42
  *FAYDKIQAH*   5       49
  *YLLYEDYTF*   9*∗*    48
  *IASFLSNPF*   6       67^\#^
  *FLSNPFAAL*   8       58
  *KSNPVQVLF*   5       0
  *LLGDIVAVS*   0       60
  *FLTDEQFTI*   3       76^\#^
  *FLEIANYQV*   2       67^\#^
  *LLRSTVSKA*   0       64

*∗*Proposed MHCI docked epitopes; ^\#^top proposed MHCII epitopes.

###### 

The binding energy and attractive VDW scores for the suggested epitopes with chicken BF2 alleles using PatchDock server.

  Ligand       Receptor     Global energy kcal/mol   Attractive VDW kcal/mol
  ------------ ------------ ------------------------ -------------------------
  YVFNVTLYY    BF~2~ 2101   -91.78                   -32.23
  BF~2~ 0401   \- 45.65     -27.43                   
                                                     
  YLLYEDYTF    BF~2~ 2101   -89.53                   -34.81
  BF~2~ 0401   -61.68       -27.77                   
                                                     
  VSYKNSYHF    BF~2~ 2101   -66.41                   -28.95
  BF~2~ 0401   -51.56       -30.71                   

[^1]: Academic Editor: Nurit Haspel
